Gravitz L, 2011.A smouldering public-health crisis,Nature 474 S2 -4
KrauseI,ValesiniG,ScrivoR,ShoenfeldY, 2003.Auto-immune aspects of cytokine and anticytokine therapies,Am J Med 115 390 -7
NiewoldTB,SwedlerWI, 2005.Systemic lupus erythematosus arising during interferon-α therapy for cryoglobulinemic vasculitis associated with hepatitis C,Clin Rheumatol 24 178 -81
Fitzgerald-BocarslyP,DaiJ,SinghS., 2008.Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history,Cytokine Growth Factor Rev 19 3 -19
HoshinoK,SugiyamaT,MatsumotoM,TanakaT,SaitoM,HemmiH, 2006.IκB kinase-α is critical for interferon-α production induced by toll-like receptors 7 and 9,Nature 440 949 -53
BarratFJ,MeekerT,GregorioJ,ChanJH,UematsuS,AkiraS, 2005.Nucleic acids of mammalian origin can act as endogenous ligands for toll-like receptors and may promote systemic lupus erythematosus,J Experi Med 202 1131 -9
FarkasA,TonelG,NestleFO, 2008.Interferon-α and viral triggers promote functional maturation of human monocyte-derived dendritic cells,Brit J Dermatol 158 921 -9
BlancoP,PaluckaAK,GillM,PascualV,BanchereauJ, 2001.Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus,Science 294 1540 -3
NiewoldTB,SwedlerWI, 2005.Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C,Clin Rheumatol 24 178 -81
NiewoldTB,HuaJ,LehmanTJ,HarleyJB,CrowMK, 2007.High serum IFN-α activity is a heritable risk factor for systemic lupus erythematosus,Genes Immun 8 492 -502